Sight Pharma
Phoenix
About Sight Pharma
Sight Pharma develops novel therapies for oncology and cardiovascular diseases in collaboration with universities.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $60.0M
- Funding stage: Private Equity
- Last round: Private Equity (Jan 2002)
- Website: sightpharma.com
- Phone: (866) 579-6379
Industries & Categories
Biotechnology, Medical, Oncology
Canonical: https://fsome.com/organization/sight-pharma-1901436 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.